Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
China’s HitGen has raised about $39 million in series B funding to grow its DNA-encoded libraries and advance its drug development programs. HitGen says it has more than 200 billion small molecules in over 900 libraries. The company has development programs in oncology, cardiovascular disease, respiratory disease, and metabolism. Its notable industry partners include BASF, Boehringer Ingelheim, Johnson & Johnson, Merck & Co., Pfizer, and Takeda.
This article has been sent to the following recipient: